177 related articles for article (PubMed ID: 35089436)
1. Sialic acid blockade in dendritic cells enhances CD8
Balneger N; Cornelissen LAM; Wassink M; Moons SJ; Boltje TJ; Bar-Ephraim YE; Das KK; Søndergaard JN; Büll C; Adema GJ
Cell Mol Life Sci; 2022 Jan; 79(2):98. PubMed ID: 35089436
[TBL] [Abstract][Full Text] [Related]
2. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation.
Büll C; Collado-Camps E; Kers-Rebel ED; Heise T; Søndergaard JN; den Brok MH; Schulte BM; Boltje TJ; Adema GJ
Immunol Cell Biol; 2017 Apr; 95(4):408-415. PubMed ID: 27874015
[TBL] [Abstract][Full Text] [Related]
3. Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity.
Büll C; Boltje TJ; Balneger N; Weischer SM; Wassink M; van Gemst JJ; Bloemendal VR; Boon L; van der Vlag J; Heise T; den Brok MH; Adema GJ
Cancer Res; 2018 Jul; 78(13):3574-3588. PubMed ID: 29703719
[TBL] [Abstract][Full Text] [Related]
4. Impact of culture medium on maturation of bone marrow-derived murine dendritic cells via the aryl hydrocarbon receptor.
Ilchmann A; Krause M; Heilmann M; Burgdorf S; Vieths S; Toda M
Mol Immunol; 2012 May; 51(1):42-50. PubMed ID: 22377453
[TBL] [Abstract][Full Text] [Related]
5. Inotodiol From
Maza PAMA; Lee JH; Kim YS; Sun GM; Sung YJ; Ponomarenko LP; Stonik VA; Ryu M; Kwak JY
Front Immunol; 2021; 12():650841. PubMed ID: 33777049
[TBL] [Abstract][Full Text] [Related]
6. The role of the e3 ligase cbl-B in murine dendritic cells.
Wallner S; Lutz-Nicoladoni C; Tripp CH; Gastl G; Baier G; Penninger JM; Stoitzner P; Wolf D
PLoS One; 2013; 8(6):e65178. PubMed ID: 23762309
[TBL] [Abstract][Full Text] [Related]
7. Herbal preparation (HemoHIM) enhanced functional maturation of bone marrow-derived dendritic cells mediated toll-like receptor 4.
Lee SJ; Kim JJ; Kang KY; Hwang YH; Jeong GY; Jo SK; Jung U; Park HR; Yee ST
BMC Complement Altern Med; 2016 Feb; 16():67. PubMed ID: 26891999
[TBL] [Abstract][Full Text] [Related]
8. Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.
Xu S; Koski GK; Faries M; Bedrosian I; Mick R; Maeurer M; Cheever MA; Cohen PA; Czerniecki BJ
J Immunol; 2003 Sep; 171(5):2251-61. PubMed ID: 12928369
[TBL] [Abstract][Full Text] [Related]
9. The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells.
Sheng KC; Kalkanidis M; Pouniotis DS; Wright MD; Pietersz GA; Apostolopoulos V
J Immunol; 2008 Aug; 181(4):2455-64. PubMed ID: 18684936
[TBL] [Abstract][Full Text] [Related]
10. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
Periasamy P; O'Neill HC
Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
12. pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.
Ozga AJ; Moalli F; Abe J; Swoger J; Sharpe J; Zehn D; Kreutzfeldt M; Merkler D; Ripoll J; Stein JV
J Exp Med; 2016 Nov; 213(12):2811-2829. PubMed ID: 27799622
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response.
Ramirez SR; Singh-Jasuja H; Warger T; Braedel-Ruoff S; Hilf N; Wiemann K; Rammensee HG; Schild H
Cell Stress Chaperones; 2005; 10(3):221-9. PubMed ID: 16184767
[TBL] [Abstract][Full Text] [Related]
14. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.
Freire-de-Lima L; Alisson-Silva F; Carvalho ST; Takiya CM; Rodrigues MM; DosReis GA; Mendonça-Previato L; Previato JO; Todeschini AR
J Biol Chem; 2010 Apr; 285(18):13388-96. PubMed ID: 20106975
[TBL] [Abstract][Full Text] [Related]
16. TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 production.
Vogel SZ; Schlickeiser S; Jürchott K; Akyuez L; Schumann J; Appelt C; Vogt K; Schröder M; Vaeth M; Berberich-Siebelt F; Lutz MB; Grütz G; Sawitzki B
J Immunol; 2015 Apr; 194(7):3136-46. PubMed ID: 25750433
[TBL] [Abstract][Full Text] [Related]
17. Early cytoskeletal rearrangement during dendritic cell maturation enhances synapse formation and Ca(2+) signaling in CD8(+) T cells.
Averbeck M; Braun T; Pfeifer G; Sleeman J; Dudda J; Martin SF; Kremer B; Aktories K; Simon JC; Termeer C
Eur J Immunol; 2004 Oct; 34(10):2708-19. PubMed ID: 15368287
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
19. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells.
Jenner J; Kerst G; Handgretinger R; Müller I
Exp Hematol; 2006 Sep; 34(9):1212-8. PubMed ID: 16939814
[TBL] [Abstract][Full Text] [Related]
20. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
